tirzepatide versus semaglutide once weekly in Patients with Type 2 Diabetes | NEJM Tirzepatide and Semaglutide key differences,

Glucagon-like peptide 1 (GLP-1) receptor agonists in experimental Alzheimer's disease: systematic review and meta-analysis

By slowing the movement of stomach contents, GLP-1 medications can significantly delay gastric emptying, with the effect being most pronounced during dose escalation

New or Worsening Food Intolerances: Sealing the tight junctions prevents large, undigested food proteins from entering the bloodstream, which reduces the immune system's hyper-reactive antibody response to previously tolerated foods

Mondelz International CEO Dirk Van de Put said the Oreo and Cadbury maker recently worked with a leading consulting firm to assess how GLP-1s affect food consumption

For those who choose to discontinue the medication, preparation and clear expectations matter

Elsevier BV, DOI 10.1016/j.diabet.2025.101636,